EVOKE NEUROSCIENCE, INC.

Evoke Neuroscience, Inc. specializes in the design, development, and delivery of advanced electromedical systems focused on brain health monitoring and data analytics. Drawing from award descriptions, the company produces proprietary neurotechnological platforms that generate clinical-grade summary reports, likely leveraging EEG-based biomarkers and machine learning algorithms to assess cognitive and neurological states. Their technical expertise centers on FDA-regulated medical device software, real-time neurosignal processing, and secure data visualization tools tailored for defense and clinical environments. Key differentiators include closed-loop reporting systems that translate complex neural data into actionable insights, with a focus on operational readiness and personnel wellness applications. The contractor has established a consistent relationship with the Department of Defense, delivering neurocognitive assessment tools and summary reporting systems to support military health and readiness programs. These engagements suggest deep integration with military medical logistics and behavioral health initiatives, where timely, standardized neurodata reporting is critical for mission performance and post-deployment care. Evoke Neuroscience operates primarily within NAICS 334510, which encompasses the manufacturing of electromedical and electrophysiological apparatus. In practice, this means they engineer certified medical devices that acquire, process, and interpret neurological signals—positioning them at the intersection of neurotechnology and defense healthcare innovation. Their market focus is niche but strategic, serving high-acuity environments requiring non-invasive, scalable brain health monitoring solutions. As a small business structured as a 2L entity based in New York, NY, Evoke Neuroscience operates without federal certifications but maintains a focused government market presence through specialized neurotech solutions. Their geographic and operational footprint is centered on supporting federal health and readiness missions with clinically validated, device-class software and hardware systems.